- Home
- FITB vs BNTX Comparison
FITB vs BNTX Comparison
Compare FITB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FITB
- BNTX
- Stock Information
- Founded
- FITB 1858
- BNTX 2008
- Country
- FITB United States
- BNTX Germany
- Employees
- FITB N/A
- BNTX N/A
- Industry
- FITB Major Banks
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FITB Finance
- BNTX Health Care
- Exchange
- FITB Nasdaq
- BNTX Nasdaq
- Market Cap
- FITB 25.6B
- BNTX 26.4B
- IPO Year
- FITB N/A
- BNTX 2019
- Fundamental
- Price
- FITB $45.49
- BNTX $102.66
- Analyst Decision
- FITB Buy
- BNTX Strong Buy
- Analyst Count
- FITB 14
- BNTX 18
- Target Price
- FITB $47.50
- BNTX $139.49
- AVG Volume (30 Days)
- FITB 3.5M
- BNTX 836.3K
- Earning Date
- FITB 10-17-2025
- BNTX 11-03-2025
- Dividend Yield
- FITB 3.24%
- BNTX N/A
- EPS Growth
- FITB 2.27
- BNTX N/A
- EPS
- FITB 3.21
- BNTX N/A
- Revenue
- FITB $7,993,000,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- FITB $15.36
- BNTX N/A
- Revenue Next Year
- FITB $4.72
- BNTX $15.19
- P/E Ratio
- FITB $14.21
- BNTX N/A
- Revenue Growth
- FITB N/A
- BNTX 6.98
- 52 Week Low
- FITB $32.25
- BNTX $81.20
- 52 Week High
- FITB $49.07
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- FITB 63.58
- BNTX 43.08
- Support Level
- FITB $44.99
- BNTX $98.96
- Resistance Level
- FITB $46.60
- BNTX $114.89
- Average True Range (ATR)
- FITB 0.74
- BNTX 3.46
- MACD
- FITB 0.11
- BNTX -0.17
- Stochastic Oscillator
- FITB 72.93
- BNTX 23.23
About FITB Fifth Third Bancorp
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.